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ABSTRACT 
 
Objective: MRSA poses a great risk to wound patients with potential to cause significant mortality and morbidity in 
human population due to the development of biofilm. So the present study was undertaken with the aim to know the 
prevalence of different microorganism from wound, to know the biofilm formation and the antimicrobial resistant 
pattern of MRSA strains. Materials & Methods: The prospective study was carried out in the department of 
Microbiology during the period of July 2012 to December 2013.Total of 85 MRSA isolated from clinical samples 
were identified by standard microbiological techniques and the isolates were further tested for biofilm formation and 
Antimicrobial susceptibility testing by Kirby-Bauer disc-diffusion method as per CLSI guidelines. Result: Among 
290 wound sample received, culture was positive in 230 (79.31%). The common pathogens were MRSA 
85(32.44%), MSSA 60(22.90%), E.coli 25(9.54%) and Pseudomonas aeruginosa 24(9.16%). Higher prevalence was 
noted in Obgy (38.82%) followed by surgery (17.65%), Skin (16.47%), ICU(9.41%), Orthopedics(7.06%), 
Medicine(4.71%), OPD(3.53%), Paediatric (2.35%),Of 85 MRSA, biofilm formation was observed in 70 (82.35%). 
Strong biofilm formation in 42(49.41%), weak biofilm formation in 28(32.94%) and negative biofilm formation in 
15(17.65%). In our study the Antimicrobial resistance pattern in strong biofilm forming MRSA isolates when 
compared to biofilm non producers was for Amikacin 57.14%/ 26.67%, Erythromycin 73.80%/ 26.67%, 
Clindamycin 66.67%/ 20%, Ciprofloxacin 90.47%/46.67%, Gentamycin 88.09%/46.67%, Fusidic acid  
35.71%/6.67%, Mupirocin  14.28%/6.67%.No resistance was noted to Linezolid and Teicoplanin Conclusions: 
Early identification and adopting efficient control protocol against biofilm forming MRSA can be one of the 
essential steps towards the prevention of the most serious nosocomial infections. 
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Introduction 
 
A wound is the result of physical disruption of the skin, 
one of the major obstacles to the establishment of 
infections by bacterial pathogens in internal tissues. 
When bacteria breach this barrier, infection can result[1, 
2] The most common underlying event for all wounds is 
trauma. Trauma may be accidental or intentionally 
induced. The latter category includes hospital-acquired 
wounds, which can be grouped according to how they 
are acquired, such as surgically and by use of 
intravenous medical devices. 
_______________________________ 
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Although not intentionally induced, hospital-acquired 
wounds can be the pressure sores caused by local 
ischemia, too. They are also referred as decubitus ulcers, 
and when such wounds become infected, they are often 
colonized by multiple bacterial species.[2]Most wound 
infections can be classified into two major categories: 
skin and soft tissue infections, although they often 
overlap as a consequence of disease progression. [2, 
3]Wound infections can be caused by different groups of 
microorganisms, most commonly isolated aerobic 
microorganisms includes S.aureus, CoNS, Enterococci, 
E.coli, P.aeurginosa, Klebsiella pneumoniae, 
Enterobacter, Pr.mirabilis, Streptococci, Candida, 
Acinetobacter. [4]The overall incidence of wound sepsis 
in India is from 10-33 %. [5]Among the Gram-positive 
pathogens, S. aureus continues to cause skin and soft 
tissue infections (SSTI) in the community as well as 
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invasive infections in the hospitalized patients and is a 
frequent cause of bacterial infections in both developed 
and developing countries. [6-8]It is a highly versatile and 
adaptable pathogen, causing a range of infections of 
varying severity affecting the skin, soft tissue, 
respiratory system, bone, joints and endovascular tissues. 
[6]MRSA poses a great risk to wound patients with 
potential to cause significant mortality and morbidity in 
human population due to the development of 
biofilm.[9]Biofilms have an enormous impact on 
healthcare, and are estimated to be associated with 65% 
of nosocomial infections.[10]Biofilms are the population 
of bacteria growing on the biotic and abiotic surfaces and 
embed themselves in a self-produced extracellular matrix 
of exopolysaccharide (EPS), proteins and some micro 
molecules such as DNA.[11]Adaptation to surface 
attached growth within a biofilm is accompanied by 
significant changes in gene and protein expression, as 
well as metabolic activity which confers resistance to 
antimicrobial therapy.[12]Biofilm formation in S. aureus 
is regulated by expression of Polysaccharide Intracellular 
Adhesion (PIA) which mediates cell to cell adhesion and 
is the gene product of ica ABDC [13].MRSA infections 
are life-threatening due to emergence of multidrug 
resistance strains and also occurrence of isolates that are 
able to form strong biofilms. 
So the present study was undertaken with the aim  
• To know the prevalence of different 
microorganism from wound 
• To know the biofilm formation of MRSA in 
wound  
• To know the antimicrobial resistant pattern of 
MRSA strains  
Materials & Methods: 
The prospective study was carried out in the department 
of Microbiology from the period of July 2012 to 
December 2013. Pus sample were collected with sterile 
disposable cotton swabs and isolates were identified by 
standard microbiological techniques.  
All the confirmed S. aureus strains were subsequently 
tested for methicillin resistance using cefoxitin disc 
(30µg). The Isolates were considered methicillin-
resistant if the zone of inhibition was 21mm or 
less.[14]All MRSA isolates was included and Repeat 
Isolates were excluded. 
• The MRSA isolates were tested for biofilm 
formation by Tube Method (TM): A qualitative 
assessment of biofilm formation was determined 
as described by Christensen et al[15]TSBglu 
(10mL) were inoculated with the loopful of 
microorganism from overnight culture plates and 
incubated for 24 hours at 37°C. The tubes were 
decanted and washed with PBS (pH 7.3) and 
dried. Dried tubes were stained with crystal violet 
(0.1%). Excess stain was removed and tubes were 
washed with deionized water. Tubes were than 
dried in inverted position and observed for biofilm 
formation. Assays were performed in triplicate at 
three different times. The data obtained was 
recorded and analyzed by using appropriate 
statistical methods. 
• The Isolates were further tested for 
Antimicrobial susceptibility testing by Kirby-
Bauer disc diffusion method on Mueller Hinton 
agar as per CLSI Approved Standard M100-
S17)[14]except for Fusidic acid where the 
French Society of Microbiology 
recommendations were used. 
• The following antimicrobial agents were tested 
amikacin (30µg), erythromycin (15µg), 
clindamycin (2µg), Ciprofloxacin (CIP) 5µg, 
Linezolid (30µg), gentamycin (30µg), fusidic 
acid (10µg), teicoplanin (30 µg) and mupirocin 
(5µg). (Discs were procured from Hi-media 
Laboratories, Mumbai, India &Oxoid) 
 
Result: 
 
Among 290 wound sample received, culture was positive 
in 230 (79.31%). A single etiologic agent was identified 
in 198(68.27%) patients, mixed etiologic agents were 
found in 32 (11.03%) and no etiologic agent was 
identified in 60(20.68%). Among the common pathogens 
were Staphylococcus aureus accounted for 145(50%) 
 
Chart No 1: Distribution of microorganism in wound 
Chart No 2: Ward-wise distribution of microorganism in wound 
Table No 1: Biofilm formation in MRSA isolates 
Table No 2: Biofilm formation and Antimicrobial resistant Pattern of MRSA among wound 
Figure No 1: Biofilm producer 
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Chart No 1: Distribution of microorganism in wound 
 
 
The above chart depicts Staphylococcus aureus; E.coli and Ps aeruginosa is the predominant organism from wound 
 
Chart No 2: Ward-wise distribution of microorganism in wound 
 
 
 
 
 
The above chart depicts higher prevalence of MRSA from Obgy(38.82%) followed by Surgical  (17.65%) 
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Table No 1: Biofilm formation in MRSA isolates 
 
Total No of MRSA isolates 
tested for Biofilm 
Total No of isolates forming Biofilm  
N=70 (82.35%) 
Strong Weak Negative 
85 42(49.41%) 28(32.94%) 15(17.65%) 
 
The above table depicts the higher percentage of biofim formation by strong biofilm former 
 
Table No 2: Biofilm formation and Antimicrobial resistant Pattern of MRSA among wound 
 
Antimicrobial agent Antibiotic Resistance pattern in 
Strong biofilm n=42 
(%) 
Weak biofilm n= 
28 (%) 
Negative biofilm n=15 
(%) 
Amikacin 24(57.14) 8(28.57) 4(26.67) 
Erythromycin  31(73.80) 15(53.57) 4(26.67) 
Clindamycin  28(66.67) 13(46.42) 3(20) 
Ciprofloxacin 38(90.47) 14(67.85) 7(46.67) 
Linezolid 0 0 0 
Gentamycin  37(88.09) 20(71.42) 6(46.67) 
Fusidic acid   15(35.71) 5(17.86) 1(6.67) 
Teicoplanin 0 0 0 
Mupirocin 5 6(14.28) 3(10.71) 1(6.67) 
 
The above table depicts the higher percentage of Antimicrobial resistant by strong biofilm former compared to negative 
biofilm former. No resistance was noted to Linezolid and Teicoplanin 
 
 
Figure 1:Biofilm Producer 
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Discussion 
 
Wound patients have been shown the potential to 
become colonized and infected more readily than other 
patients due to deprivation of mechanical barrier 
provided by the skin and mucous membrane as well as 
the depression of immunological response. [9]Pathogens 
that infect wounds can be part of normal flora or 
acquired from the hospital environment or other infected 
patients. Staphylococcus aureus, being the normal 
microbial flora of the skin, is one of the commonest 
causes of wound infections. Its increasing incidence is a 
growing concern with emergence of virulent, antibiotic 
resistant strains in the community settings.[16] 
The important reservoirs of MRSA in hospitals/ 
institutions are infected or colonized patients and 
transient hand carriage is the predominant mode for 
patient to patient transmission. In India, the significance 
of MRSA has been recognized relatively late and 
epidemic strains of these MRSA strains are usually 
resistant to several antibiotics. During the last 15 years, 
the appearance and world wide spread of many such 
clones have caused major therapeutic problems in many 
hospitals, as well as diversion of considerable resources 
to attempts at controlling their spread.[17]A considerable 
increase in the prevalence of MRSA has been observed 
globally during the last decade. [18] 
In our study the predominant organisms were 
Staphylococcus aureus (50%), E.coli (9.54%) and Ps 
aeruginosa (9.16%).  Similar were the findings of 
Mohanty et al who reported S. aureus, E. coli and 
Pseudomonas spp. are the top 3 pathogens isolated from 
skin and soft tissue infections in hospitalized patients. 
[19]In the present study the prevalence of MRSA in 
wound was 85 (32.44%). Similar were the findings of 
Mohanty 38.56%, Singh 45%. [19, 20]Sangeeta Joshi et 
al, INSAR observed the prevalence of MRSA isolated 
from skin and soft tissue infections (36% in 2008 and 
40% in 2009) [ 21].The prevalence varies considerably 
from one region to another and among hospitals in the 
same city. Methicillin resistance in S. aureus isolates 
(mostly health-care-associated MRSA) varies from less 
than 1 % in Norway, Sweden and Denmark, less than 5 
% in the Netherlands, 5 - 10 % in Canada, 40 % in 
Greece and the United Kingdom of Great Britain and 
Northern Ireland, 25 - 50 % in the USA, 37.5 % in India, 
to more than 50 % in China, Hong Kong SAR and 
Singapore.[22, 23]In Japan, the percentage of MRSA 
isolated from skin infections have been shown to vary 
from 10 to 20%.[24]About 51.6 % of S. aureus isolates 
among patients admitted to burns and orthopedics units 
in India were reported to be MRSA. [ 25] 
Maximum MRSA isolates 27(31.76%) were observed in 
the age group of 21-30 years followed by 14(16.47%) in 
31-40 yrs age group. the predominance of the MRSA 
was higher among females 50(58.82%) than males 35 
(41.17%). 
Having the ability of biofilm-formation decrease their 
susceptibility to antibiotics. Staphylococcus aureus is 
known to form biofilms on different surfaces. In fact 
biofilms can resist antibiotic concentration 10-10,000 
folds higher than those required to inhibit the growth of 
free floating bacteria.[26] 
Of 85 MRSA, biofilm formation was observed in 70 
(82.35%). Strong biofilm formation in 42(49.41%), weak 
biofilm formation in 28(32.94%) and negative biofilm 
formation in 15(17.65%).S Singh reported 85.72% 
(36/42) of the isolates were found to be high biofilm 
formers.[27]Sasirekha B reported 61.90% of MRSA 
isolates have the potential to make biofilm and in their 
study biofilm producing MRSA showed high resistance 
to almost all the groups of antibiotics compared to the 
biofilm non- producer. [28]Similar were the observation 
of Fatima Khan et al.,[29]Antimicrobial resistance is an 
innate feature of bacterial biofilms that, in addition to the 
increasing rates of reported antimicrobial resistance 
amongst clinical strains, may further complicate patient 
treatment. In our study the antibiotic resistance pattern in 
strong biofilm forming MRSA isolates when compared 
to biofilm non producers in percentage was for 
Amikacin57.14/ 26.67, Erythromycin73.80/ 26.67, 
Clindamycin66.67/ 20, Ciprofloxacin90.47/46.67, 
Gentamycin 88.09/46.67, Fusidic acid  35.71/6.67, 
Mupirocin  14.28/6.67.Fatima Khan et al., observed for 
Amikacin 73.53/55.43, Ciprofloxacin 83.53/76.09, 
Clindamycin 87.79/78.26, Cotrimoxazole 93.60/79.35, 
Erythromycin 65.29/53.26, Gatifloxacin 48.23/40.22, 
Gentamycin 70.00/67.39, Levofloxacin 12.35/6.42, 
Ofloxacin 24.71/21.74, Sparfloxacin 43.53/33.69. 
However they found all the strains were sensitive to 
Linezolid and vancomycin.[29]In our study we observed 
the isolates were sensitive to Linezolid and teicoplanin 
(100%).The age of the biofilm also affects its 
susceptibility to antibiotics. Older (10-day-old) biofilms 
are significantly more resistant than 2-day-old biofilms. 
This emphasizes the need for prompt diagnosis and 
treatment.[30] 
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Conclusion 
Methicillin resistance in S. aureus restricts therapeutic 
options for clinical isolates and the incidence of MRSA 
is escalating in India. The threat of MRSA infections 
results from not only the occurrence of multidrug 
resistance but also the emergence of bacteria that form 
strong biofilms. Early identification and adopting 
efficient control protocol against biofilm forming MRSA 
can be one of the essential steps towards the prevention 
of the most serious nosocomial infections.Routine 
surveillance for hospital-acquired wound infections is 
recommended by both the Centers for Disease Control 
and Prevention and the Surgical Infection Society. 
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